For more VICC news, visit their website »
The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center.
Carlos Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to lead two newly created cancer research initiatives at the Vanderbilt-Ingram Cancer Center.
An antioxidant enzyme also functions as a tumor suppressor to limit cancer development in the esophagus.
Harold L. (Hal) Moses, M.D., professor of Medicine and Pathology, acting chair of Cancer Biology and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has received the 10th annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research.
Accessibility Tools